Monovalent Moderna COVID-19 Booster Vaccine May Be Tied To Elevated Risk For New-Onset Chronic Spontaneous Urticaria, Study Suggests

MedPage Today (2/1, Short) reports, “The monovalent Moderna COVID-19 booster vaccine may be associated with an elevated risk for new-onset chronic spontaneous urticaria (CSU), or hives lasting more than 6 weeks, according to a Swiss study.” Among individu...